Plain-English translation of NCT00969111 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing radiation therapy — delivered either as proton radiation or conventional radiation — for men whose prostate cancer has already returned after surgery, or who are at high risk for it to return. Depending on your situation, you may also receive hormone therapy alongside the radiation. The study aims to understand how well this treatment works and what side effects patients experience.
After prostate removal surgery, some men's cancer returns or they remain at risk for recurrence. This trial exists to find the best way to use radiation therapy — alone or with hormone therapy — to prevent cancer from coming back and to compare different types of radiation delivery.
You likely qualify if…
You likely don't qualify if…
You will receive a course of radiation therapy tailored to your specific situation — either proton radiation, conventional radiation, or a combination of both, possibly with hormone therapy if you are at higher risk. The radiation is delivered to the area where your prostate was removed. Your treatment plan and number of visits will depend on which group you are assigned to, but you can expect multiple visits over several weeks.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States